This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
n13http://linked.opendata.cz/resource/drugbank/drug/DB08340/identifier/pubchem-compound/
dctermshttp://purl.org/dc/terms/
n14http://linked.opendata.cz/resource/drugbank/drug/DB08340/identifier/pubchem-substance/
n9http://linked.opendata.cz/resource/drugbank/drug/DB08340/identifier/drugbank/
n10http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n12http://linked.opendata.cz/resource/drugbank/drug/DB08340/identifier/chemspider/
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n11http://linked.opendata.cz/resource/drugbank/drug/DB08340/identifier/pdb/

Statements

Subject Item
n2:DB08340
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB08340 n10:DB08340
dcterms:title
N,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE-2,4-DIAMINE
adms:identifier
n9:DB08340 n11:P19 n12:22377916 n13:24779674 n14:99444811
n3:IUPAC-Name
n4:271B4EA9-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4EAF-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4EAE-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4EAB-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4EAC-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4EAD-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4EA7-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4EA5-363D-11E5-9242-09173F13E4C5 n4:271B4EA8-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4EA6-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4EB5-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4EB6-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4EB0-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4EB1-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4EB3-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4EB2-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4EB4-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4EBB-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4EBD-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4EBE-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4EBA-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4EB9-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4EBC-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4EAA-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4EB7-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4EB8-363D-11E5-9242-09173F13E4C5